Although, both routes of administration of IL-21, subcutaneous (s.c.)or i.p., induced antitumor effects in mice bearing established melanoma or renal cell carcinoma, only s.c. route inhibited the growth of large tumors. This evidence concerns the gene IL21 and renal cell carcinoma.